Literature DB >> 34341717

Diagnostic accuracy of 18F-FDG PET/CT scan for peritoneal metastases in advanced ovarian cancer.

Zheng Feng1,2, Shuai Liu2,3,4,5, Xingzhu Ju1,2, Xiaojun Chen1,2, Ruimin Li2,6, Rui Bi2,7, Xiaohua Wu1,2.   

Abstract

BACKGROUND: To assess the diagnostic accuracy of 18F-FDG PET/CT to determine the Eisenkop score and peritoneal cancer index (PCI) in correlation with surgical findings.
METHODS: Forty-three patients underwent preoperative 18F-FDG PET/CT scan, followed by primary cytoreductive surgery for advanced ovarian cancer between September 2015 and February 2018. Clinical data were prospectively collected, including intraoperative assessment (with Eisenkop and PCI scores) and surgical results. The sensitivity, specificity, and accuracy were calculated at each anatomical site. The Eisenkop score, PCI score, and tumor volume of PET/CT scans were compared with surgical findings.
RESULTS: A total of 32 (74.4%) patients were diagnosed with stage III, and 11 (25.6%) patients were stage IV. Among these individuals, 19 (44.2%) patients had no residual disease after primary surgery. The median [range] Eisenkop score on PET/CT scans and surgical findings were 5 [1-13] and 6 [2-13], respectively. PET/CT scans correctly predicted the Eisenkop score with high sensitivity (84.2%), specificity (87.0%), and accuracy (85.1%). The diagnostic accuracy of PET/CT scans for PCI scores was lower (78.5%), with 72.7% sensitivity and 84.9% specificity. Preoperative PET/CT scans might underestimate tumor volume compared with surgical findings.
CONCLUSIONS: 18F-FDG PET/CT scans accurately predicted peritoneal metastases in advanced ovarian cancer before surgery using Eisenkop score. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  18F-FDG PET/CT; Eisenkop score; Ovarian cancer; peritoneal cancer index (PCI); peritoneal metastases

Year:  2021        PMID: 34341717      PMCID: PMC8245942          DOI: 10.21037/qims-20-784

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  22 in total

1.  Positron emission tomography-laparoscopy based method in the prediction of complete cytoreduction in platinum-sensitive recurrent ovarian cancer.

Authors:  Francesco Fanfani; Giorgia Monterossi; Anna Fagotti; Valerio Gallotta; Barbara Costantini; Giuseppe Vizzielli; Marco Petrillo; Maria Vittoria Carbone; Giovanni Scambia
Journal:  Ann Surg Oncol       Date:  2014-08-26       Impact factor: 5.344

2.  Computed tomography prior to surgery for ovarian carcinoma.

Authors:  A Simon; S Fields; J G Schenker; S O Anteby
Journal:  Aust N Z J Obstet Gynaecol       Date:  1986-08       Impact factor: 2.100

3.  Peritoneal implants from ovarian tumors: CT findings.

Authors:  J N Buy; A A Moss; M A Ghossain; C Sciot; L Malbec; D Vadrot; B J Paniel; Y Decroix
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

4.  Evaluation of preoperative investigations in patients admitted for ovarian primary cytoreductive surgery.

Authors:  F Guidozzi; E W Sonnendecker
Journal:  Gynecol Oncol       Date:  1991-03       Impact factor: 5.482

5.  Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer.

Authors:  Signe Risum; Annika Loft; Claus Høgdall; Anne K Berthelsen; Estrid Høgdall; Lene Lundvall; Lotte Nedergaard; Svend A Engelholm
Journal:  Acta Oncol       Date:  2010-08-11       Impact factor: 4.089

6.  Diagnostic value of preoperative SUVmax on FDG-PET/CT for the detection of ovarian cancer.

Authors:  Yuko Tanizaki; Aya Kobayashi; Michihisa Shiro; Nami Ota; Rei Takano; Yasushi Mabuchi; Shigetaka Yagi; Sawako Minami; Masaki Terada; Kazuhiko Ino
Journal:  Int J Gynecol Cancer       Date:  2014-03       Impact factor: 3.437

7.  The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.

Authors:  W J Hoskins; W P McGuire; M F Brady; H D Homesley; W T Creasman; M Berman; H Ball; J S Berek
Journal:  Am J Obstet Gynecol       Date:  1994-04       Impact factor: 8.661

8.  A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study.

Authors:  G Omura; J A Blessing; C E Ehrlich; A Miller; E Yordan; W T Creasman; H D Homesley
Journal:  Cancer       Date:  1986-05-01       Impact factor: 6.860

9.  A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study.

Authors:  Zheng Feng; Hao Wen; Zhaoxia Jiang; Shuai Liu; Xingzhu Ju; Xiaojun Chen; Lingfang Xia; Junyan Xu; Rui Bi; Xiaohua Wu
Journal:  J Gynecol Oncol       Date:  2018-04-23       Impact factor: 4.401

10.  Preoperative PET/CT score can predict complete resection in advanced epithelial ovarian cancer: a prospective study.

Authors:  Bingxin Gu; Lingfang Xia; Huijuan Ge; Shuai Liu
Journal:  Quant Imaging Med Surg       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.